Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus.

Identifieur interne : 003B45 ( Ncbi/Merge ); précédent : 003B44; suivant : 003B46

Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus.

Auteurs : Anthony Brown [Royaume-Uni] ; John S. Halliday [Royaume-Uni] ; Leo Swadling [Royaume-Uni] ; Richie G. Madden [Royaume-Uni] ; Richard Bendall [Royaume-Uni] ; Jeremy G. Hunter [Royaume-Uni] ; James Maggs [Royaume-Uni] ; Peter Simmonds [Royaume-Uni] ; Donald B. Smith [Royaume-Uni] ; Louisa Vine [Royaume-Uni] ; Cara Mclaughlin [Royaume-Uni] ; Jane Collier [Royaume-Uni] ; David Bonsall [Royaume-Uni] ; Katie Jeffery [Royaume-Uni] ; Susanna Dunachie [Royaume-Uni] ; Paul Klenerman [Royaume-Uni] ; Jacques Izopet [France] ; Nassim Kamar [France] ; Harry R. Dalton [Royaume-Uni] ; Eleanor Barnes [Royaume-Uni]

Source :

RBID : pubmed:27631819

Descripteurs français

English descriptors

Abstract

The interplay between host antiviral immunity and immunopathology during hepatitis E virus (HEV) infection determines important clinical outcomes. We characterized the specificity, functionality, and durability of host T-cell responses against the full-length HEV virus and assessed a novel "Quantiferon" assay for the rapid diagnosis of HEV infection. Eighty-nine volunteers were recruited from Oxford, Truro (UK), and Toulouse (France), including 44 immune-competent patients with acute HEV infection, 18 HEV-exposed immunosuppressed organ-transplant recipients (8 with chronic HEV), and 27 healthy volunteers. A genotype 3a peptide library (616 overlapping peptides spanning open reading frames [ORFs] 1-3) was used in interferon-gamma (IFN-γ) T-cell ELISpot assays. CD4(+) /CD8(+) T-cell subsets and polyfunctionality were defined using ICCS and SPICE analysis. Quantification of IFN-γ used whole-blood stimulation with recombinant HEV-capsid protein in the QuantiFERON kit. HEV-specific T-cell responses were detected in 41/44 immune-competent HEV exposed volunteers (median magnitude: 397 spot-forming units/10(6) peripheral blood mononuclear cells), most frequently targeting ORF2. High-magnitude, polyfunctional CD4 and CD8(+) T cells were detected during acute disease and maintained to 12 years, but these declined over time, with CD8(+) responses becoming more monofunctional. Low-level responses were detectable in immunosuppressed patients. Twenty-three novel HEV CD4(+) and CD8(+) T-cell targets were mapped predominantly to conserved genomic regions. QuantiFERON testing demonstrated an inverse correlation between IFN-γ production and the time from clinical presentation, providing 100% specificity, and 71% sensitivity (area under the receiver operator characteristic curve of 0.86) for HEV exposure at 0.3 IU/mL.

DOI: 10.1002/hep.28819
PubMed: 27631819

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:27631819

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus.</title>
<author>
<name sortKey="Brown, Anthony" sort="Brown, Anthony" uniqKey="Brown A" first="Anthony" last="Brown">Anthony Brown</name>
<affiliation wicri:level="4">
<nlm:affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
<settlement type="city">Oxford</settlement>
</placeName>
<orgName type="university">Université d'Oxford</orgName>
</affiliation>
</author>
<author>
<name sortKey="Halliday, John S" sort="Halliday, John S" uniqKey="Halliday J" first="John S" last="Halliday">John S. Halliday</name>
<affiliation wicri:level="4">
<nlm:affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
<settlement type="city">Oxford</settlement>
</placeName>
<orgName type="university">Université d'Oxford</orgName>
</affiliation>
</author>
<author>
<name sortKey="Swadling, Leo" sort="Swadling, Leo" uniqKey="Swadling L" first="Leo" last="Swadling">Leo Swadling</name>
<affiliation wicri:level="4">
<nlm:affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
<settlement type="city">Oxford</settlement>
</placeName>
<orgName type="university">Université d'Oxford</orgName>
</affiliation>
</author>
<author>
<name sortKey="Madden, Richie G" sort="Madden, Richie G" uniqKey="Madden R" first="Richie G" last="Madden">Richie G. Madden</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Royal Cornwall Hospital, Truro, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Royal Cornwall Hospital, Truro</wicri:regionArea>
<wicri:noRegion>Truro</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bendall, Richard" sort="Bendall, Richard" uniqKey="Bendall R" first="Richard" last="Bendall">Richard Bendall</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Royal Cornwall Hospital, Truro, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Royal Cornwall Hospital, Truro</wicri:regionArea>
<wicri:noRegion>Truro</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hunter, Jeremy G" sort="Hunter, Jeremy G" uniqKey="Hunter J" first="Jeremy G" last="Hunter">Jeremy G. Hunter</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Royal Cornwall Hospital, Truro, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Royal Cornwall Hospital, Truro</wicri:regionArea>
<wicri:noRegion>Truro</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Maggs, James" sort="Maggs, James" uniqKey="Maggs J" first="James" last="Maggs">James Maggs</name>
<affiliation wicri:level="3">
<nlm:affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Oxford University Hospitals NHS Foundation Trust, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Simmonds, Peter" sort="Simmonds, Peter" uniqKey="Simmonds P" first="Peter" last="Simmonds">Peter Simmonds</name>
<affiliation wicri:level="4">
<nlm:affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
<settlement type="city">Oxford</settlement>
</placeName>
<orgName type="university">Université d'Oxford</orgName>
</affiliation>
</author>
<author>
<name sortKey="Smith, Donald B" sort="Smith, Donald B" uniqKey="Smith D" first="Donald B" last="Smith">Donald B. Smith</name>
<affiliation wicri:level="4">
<nlm:affiliation>Centre for Immunity, Infection and Evolution, University of Edinburgh, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Centre for Immunity, Infection and Evolution, University of Edinburgh</wicri:regionArea>
<placeName>
<settlement type="city">Édimbourg</settlement>
<region type="country">Écosse</region>
</placeName>
<orgName type="university">Université d'Édimbourg</orgName>
</affiliation>
</author>
<author>
<name sortKey="Vine, Louisa" sort="Vine, Louisa" uniqKey="Vine L" first="Louisa" last="Vine">Louisa Vine</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Royal Cornwall Hospital, Truro, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Royal Cornwall Hospital, Truro</wicri:regionArea>
<wicri:noRegion>Truro</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mclaughlin, Cara" sort="Mclaughlin, Cara" uniqKey="Mclaughlin C" first="Cara" last="Mclaughlin">Cara Mclaughlin</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Royal Cornwall Hospital, Truro, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Royal Cornwall Hospital, Truro</wicri:regionArea>
<wicri:noRegion>Truro</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Collier, Jane" sort="Collier, Jane" uniqKey="Collier J" first="Jane" last="Collier">Jane Collier</name>
<affiliation wicri:level="3">
<nlm:affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Oxford University Hospitals NHS Foundation Trust, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bonsall, David" sort="Bonsall, David" uniqKey="Bonsall D" first="David" last="Bonsall">David Bonsall</name>
<affiliation wicri:level="4">
<nlm:affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
<settlement type="city">Oxford</settlement>
</placeName>
<orgName type="university">Université d'Oxford</orgName>
</affiliation>
</author>
<author>
<name sortKey="Jeffery, Katie" sort="Jeffery, Katie" uniqKey="Jeffery K" first="Katie" last="Jeffery">Katie Jeffery</name>
<affiliation wicri:level="3">
<nlm:affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Oxford University Hospitals NHS Foundation Trust, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Dunachie, Susanna" sort="Dunachie, Susanna" uniqKey="Dunachie S" first="Susanna" last="Dunachie">Susanna Dunachie</name>
<affiliation wicri:level="4">
<nlm:affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
<settlement type="city">Oxford</settlement>
</placeName>
<orgName type="university">Université d'Oxford</orgName>
</affiliation>
</author>
<author>
<name sortKey="Klenerman, Paul" sort="Klenerman, Paul" uniqKey="Klenerman P" first="Paul" last="Klenerman">Paul Klenerman</name>
<affiliation wicri:level="4">
<nlm:affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
<settlement type="city">Oxford</settlement>
</placeName>
<orgName type="university">Université d'Oxford</orgName>
</affiliation>
</author>
<author>
<name sortKey="Izopet, Jacques" sort="Izopet, Jacques" uniqKey="Izopet J" first="Jacques" last="Izopet">Jacques Izopet</name>
<affiliation wicri:level="3">
<nlm:affiliation>The Rangueil Hospital, Toulouse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>The Rangueil Hospital, Toulouse</wicri:regionArea>
<placeName>
<region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kamar, Nassim" sort="Kamar, Nassim" uniqKey="Kamar N" first="Nassim" last="Kamar">Nassim Kamar</name>
<affiliation wicri:level="3">
<nlm:affiliation>The Rangueil Hospital, Toulouse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>The Rangueil Hospital, Toulouse</wicri:regionArea>
<placeName>
<region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Dalton, Harry R" sort="Dalton, Harry R" uniqKey="Dalton H" first="Harry R" last="Dalton">Harry R. Dalton</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Royal Cornwall Hospital, Truro, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Royal Cornwall Hospital, Truro</wicri:regionArea>
<wicri:noRegion>Truro</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Barnes, Eleanor" sort="Barnes, Eleanor" uniqKey="Barnes E" first="Eleanor" last="Barnes">Eleanor Barnes</name>
<affiliation wicri:level="4">
<nlm:affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
<settlement type="city">Oxford</settlement>
</placeName>
<orgName type="university">Université d'Oxford</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27631819</idno>
<idno type="pmid">27631819</idno>
<idno type="doi">10.1002/hep.28819</idno>
<idno type="wicri:Area/PubMed/Corpus">001442</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001442</idno>
<idno type="wicri:Area/PubMed/Curation">001420</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001420</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001420</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001420</idno>
<idno type="wicri:Area/Ncbi/Merge">003B45</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus.</title>
<author>
<name sortKey="Brown, Anthony" sort="Brown, Anthony" uniqKey="Brown A" first="Anthony" last="Brown">Anthony Brown</name>
<affiliation wicri:level="4">
<nlm:affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
<settlement type="city">Oxford</settlement>
</placeName>
<orgName type="university">Université d'Oxford</orgName>
</affiliation>
</author>
<author>
<name sortKey="Halliday, John S" sort="Halliday, John S" uniqKey="Halliday J" first="John S" last="Halliday">John S. Halliday</name>
<affiliation wicri:level="4">
<nlm:affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
<settlement type="city">Oxford</settlement>
</placeName>
<orgName type="university">Université d'Oxford</orgName>
</affiliation>
</author>
<author>
<name sortKey="Swadling, Leo" sort="Swadling, Leo" uniqKey="Swadling L" first="Leo" last="Swadling">Leo Swadling</name>
<affiliation wicri:level="4">
<nlm:affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
<settlement type="city">Oxford</settlement>
</placeName>
<orgName type="university">Université d'Oxford</orgName>
</affiliation>
</author>
<author>
<name sortKey="Madden, Richie G" sort="Madden, Richie G" uniqKey="Madden R" first="Richie G" last="Madden">Richie G. Madden</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Royal Cornwall Hospital, Truro, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Royal Cornwall Hospital, Truro</wicri:regionArea>
<wicri:noRegion>Truro</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bendall, Richard" sort="Bendall, Richard" uniqKey="Bendall R" first="Richard" last="Bendall">Richard Bendall</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Royal Cornwall Hospital, Truro, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Royal Cornwall Hospital, Truro</wicri:regionArea>
<wicri:noRegion>Truro</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hunter, Jeremy G" sort="Hunter, Jeremy G" uniqKey="Hunter J" first="Jeremy G" last="Hunter">Jeremy G. Hunter</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Royal Cornwall Hospital, Truro, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Royal Cornwall Hospital, Truro</wicri:regionArea>
<wicri:noRegion>Truro</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Maggs, James" sort="Maggs, James" uniqKey="Maggs J" first="James" last="Maggs">James Maggs</name>
<affiliation wicri:level="3">
<nlm:affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Oxford University Hospitals NHS Foundation Trust, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Simmonds, Peter" sort="Simmonds, Peter" uniqKey="Simmonds P" first="Peter" last="Simmonds">Peter Simmonds</name>
<affiliation wicri:level="4">
<nlm:affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
<settlement type="city">Oxford</settlement>
</placeName>
<orgName type="university">Université d'Oxford</orgName>
</affiliation>
</author>
<author>
<name sortKey="Smith, Donald B" sort="Smith, Donald B" uniqKey="Smith D" first="Donald B" last="Smith">Donald B. Smith</name>
<affiliation wicri:level="4">
<nlm:affiliation>Centre for Immunity, Infection and Evolution, University of Edinburgh, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Centre for Immunity, Infection and Evolution, University of Edinburgh</wicri:regionArea>
<placeName>
<settlement type="city">Édimbourg</settlement>
<region type="country">Écosse</region>
</placeName>
<orgName type="university">Université d'Édimbourg</orgName>
</affiliation>
</author>
<author>
<name sortKey="Vine, Louisa" sort="Vine, Louisa" uniqKey="Vine L" first="Louisa" last="Vine">Louisa Vine</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Royal Cornwall Hospital, Truro, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Royal Cornwall Hospital, Truro</wicri:regionArea>
<wicri:noRegion>Truro</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mclaughlin, Cara" sort="Mclaughlin, Cara" uniqKey="Mclaughlin C" first="Cara" last="Mclaughlin">Cara Mclaughlin</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Royal Cornwall Hospital, Truro, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Royal Cornwall Hospital, Truro</wicri:regionArea>
<wicri:noRegion>Truro</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Collier, Jane" sort="Collier, Jane" uniqKey="Collier J" first="Jane" last="Collier">Jane Collier</name>
<affiliation wicri:level="3">
<nlm:affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Oxford University Hospitals NHS Foundation Trust, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bonsall, David" sort="Bonsall, David" uniqKey="Bonsall D" first="David" last="Bonsall">David Bonsall</name>
<affiliation wicri:level="4">
<nlm:affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
<settlement type="city">Oxford</settlement>
</placeName>
<orgName type="university">Université d'Oxford</orgName>
</affiliation>
</author>
<author>
<name sortKey="Jeffery, Katie" sort="Jeffery, Katie" uniqKey="Jeffery K" first="Katie" last="Jeffery">Katie Jeffery</name>
<affiliation wicri:level="3">
<nlm:affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Oxford University Hospitals NHS Foundation Trust, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Dunachie, Susanna" sort="Dunachie, Susanna" uniqKey="Dunachie S" first="Susanna" last="Dunachie">Susanna Dunachie</name>
<affiliation wicri:level="4">
<nlm:affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
<settlement type="city">Oxford</settlement>
</placeName>
<orgName type="university">Université d'Oxford</orgName>
</affiliation>
</author>
<author>
<name sortKey="Klenerman, Paul" sort="Klenerman, Paul" uniqKey="Klenerman P" first="Paul" last="Klenerman">Paul Klenerman</name>
<affiliation wicri:level="4">
<nlm:affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
<settlement type="city">Oxford</settlement>
</placeName>
<orgName type="university">Université d'Oxford</orgName>
</affiliation>
</author>
<author>
<name sortKey="Izopet, Jacques" sort="Izopet, Jacques" uniqKey="Izopet J" first="Jacques" last="Izopet">Jacques Izopet</name>
<affiliation wicri:level="3">
<nlm:affiliation>The Rangueil Hospital, Toulouse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>The Rangueil Hospital, Toulouse</wicri:regionArea>
<placeName>
<region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kamar, Nassim" sort="Kamar, Nassim" uniqKey="Kamar N" first="Nassim" last="Kamar">Nassim Kamar</name>
<affiliation wicri:level="3">
<nlm:affiliation>The Rangueil Hospital, Toulouse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>The Rangueil Hospital, Toulouse</wicri:regionArea>
<placeName>
<region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Dalton, Harry R" sort="Dalton, Harry R" uniqKey="Dalton H" first="Harry R" last="Dalton">Harry R. Dalton</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Royal Cornwall Hospital, Truro, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Royal Cornwall Hospital, Truro</wicri:regionArea>
<wicri:noRegion>Truro</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Barnes, Eleanor" sort="Barnes, Eleanor" uniqKey="Barnes E" first="Eleanor" last="Barnes">Eleanor Barnes</name>
<affiliation wicri:level="4">
<nlm:affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
<settlement type="city">Oxford</settlement>
</placeName>
<orgName type="university">Université d'Oxford</orgName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Hepatology (Baltimore, Md.)</title>
<idno type="eISSN">1527-3350</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Hepatitis E (blood)</term>
<term>Hepatitis E (diagnosis)</term>
<term>Hepatitis E (immunology)</term>
<term>Hepatitis E (virology)</term>
<term>Hepatitis E virus (immunology)</term>
<term>Humans</term>
<term>Interferon-gamma (blood)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>T-Cell Antigen Receptor Specificity</term>
<term>T-Lymphocytes (immunology)</term>
<term>T-Lymphocytes (virology)</term>
<term>Time Factors</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hépatite E (diagnostic)</term>
<term>Hépatite E (immunologie)</term>
<term>Hépatite E (sang)</term>
<term>Hépatite E (virologie)</term>
<term>Interféron gamma (sang)</term>
<term>Jeune adulte</term>
<term>Lymphocytes T (immunologie)</term>
<term>Lymphocytes T (virologie)</term>
<term>Mâle</term>
<term>Spécificité antigénique des récepteurs des lymphocytes T</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Virus de l'hépatite E (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Interferon-gamma</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en">
<term>Hepatitis E</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Hepatitis E</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Hépatite E</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Hépatite E</term>
<term>Lymphocytes T</term>
<term>Virus de l'hépatite E</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Hepatitis E</term>
<term>Hepatitis E virus</term>
<term>T-Lymphocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Hépatite E</term>
<term>Interféron gamma</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Hépatite E</term>
<term>Lymphocytes T</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Hepatitis E</term>
<term>T-Lymphocytes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>T-Cell Antigen Receptor Specificity</term>
<term>Time Factors</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Spécificité antigénique des récepteurs des lymphocytes T</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The interplay between host antiviral immunity and immunopathology during hepatitis E virus (HEV) infection determines important clinical outcomes. We characterized the specificity, functionality, and durability of host T-cell responses against the full-length HEV virus and assessed a novel "Quantiferon" assay for the rapid diagnosis of HEV infection. Eighty-nine volunteers were recruited from Oxford, Truro (UK), and Toulouse (France), including 44 immune-competent patients with acute HEV infection, 18 HEV-exposed immunosuppressed organ-transplant recipients (8 with chronic HEV), and 27 healthy volunteers. A genotype 3a peptide library (616 overlapping peptides spanning open reading frames [ORFs] 1-3) was used in interferon-gamma (IFN-γ) T-cell ELISpot assays. CD4(+) /CD8(+) T-cell subsets and polyfunctionality were defined using ICCS and SPICE analysis. Quantification of IFN-γ used whole-blood stimulation with recombinant HEV-capsid protein in the QuantiFERON kit. HEV-specific T-cell responses were detected in 41/44 immune-competent HEV exposed volunteers (median magnitude: 397 spot-forming units/10(6) peripheral blood mononuclear cells), most frequently targeting ORF2. High-magnitude, polyfunctional CD4 and CD8(+) T cells were detected during acute disease and maintained to 12 years, but these declined over time, with CD8(+) responses becoming more monofunctional. Low-level responses were detectable in immunosuppressed patients. Twenty-three novel HEV CD4(+) and CD8(+) T-cell targets were mapped predominantly to conserved genomic regions. QuantiFERON testing demonstrated an inverse correlation between IFN-γ production and the time from clinical presentation, providing 100% specificity, and 71% sensitivity (area under the receiver operator characteristic curve of 0.86) for HEV exposure at 0.3 IU/mL.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">27631819</PMID>
<DateCreated>
<Year>2016</Year>
<Month>09</Month>
<Day>15</Day>
</DateCreated>
<DateCompleted>
<Year>2017</Year>
<Month>07</Month>
<Day>31</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>09</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1527-3350</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>64</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2016</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Hepatology (Baltimore, Md.)</Title>
<ISOAbbreviation>Hepatology</ISOAbbreviation>
</Journal>
<ArticleTitle>Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus.</ArticleTitle>
<Pagination>
<MedlinePgn>1934-1950</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/hep.28819</ELocationID>
<Abstract>
<AbstractText>The interplay between host antiviral immunity and immunopathology during hepatitis E virus (HEV) infection determines important clinical outcomes. We characterized the specificity, functionality, and durability of host T-cell responses against the full-length HEV virus and assessed a novel "Quantiferon" assay for the rapid diagnosis of HEV infection. Eighty-nine volunteers were recruited from Oxford, Truro (UK), and Toulouse (France), including 44 immune-competent patients with acute HEV infection, 18 HEV-exposed immunosuppressed organ-transplant recipients (8 with chronic HEV), and 27 healthy volunteers. A genotype 3a peptide library (616 overlapping peptides spanning open reading frames [ORFs] 1-3) was used in interferon-gamma (IFN-γ) T-cell ELISpot assays. CD4(+) /CD8(+) T-cell subsets and polyfunctionality were defined using ICCS and SPICE analysis. Quantification of IFN-γ used whole-blood stimulation with recombinant HEV-capsid protein in the QuantiFERON kit. HEV-specific T-cell responses were detected in 41/44 immune-competent HEV exposed volunteers (median magnitude: 397 spot-forming units/10(6) peripheral blood mononuclear cells), most frequently targeting ORF2. High-magnitude, polyfunctional CD4 and CD8(+) T cells were detected during acute disease and maintained to 12 years, but these declined over time, with CD8(+) responses becoming more monofunctional. Low-level responses were detectable in immunosuppressed patients. Twenty-three novel HEV CD4(+) and CD8(+) T-cell targets were mapped predominantly to conserved genomic regions. QuantiFERON testing demonstrated an inverse correlation between IFN-γ production and the time from clinical presentation, providing 100% specificity, and 71% sensitivity (area under the receiver operator characteristic curve of 0.86) for HEV exposure at 0.3 IU/mL.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Robust HEV-specific T-cell responses generated during acute disease predominantly target ORF2, but decline in magnitude and polyfunctionality over time. Defining HEV T-cell targets will be important for the investigation of HEV-associated autoimmune disease. (Hepatology 2016;64:1934-1950).</AbstractText>
<CopyrightInformation>© 2016 The Authors. Hepatology published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Brown</LastName>
<ForeName>Anthony</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Halliday</LastName>
<ForeName>John S</ForeName>
<Initials>JS</Initials>
<AffiliationInfo>
<Affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>The Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Swadling</LastName>
<ForeName>Leo</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Madden</LastName>
<ForeName>Richie G</ForeName>
<Initials>RG</Initials>
<AffiliationInfo>
<Affiliation>The Royal Cornwall Hospital, Truro, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bendall</LastName>
<ForeName>Richard</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>The Royal Cornwall Hospital, Truro, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hunter</LastName>
<ForeName>Jeremy G</ForeName>
<Initials>JG</Initials>
<AffiliationInfo>
<Affiliation>The Royal Cornwall Hospital, Truro, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maggs</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Simmonds</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Centre for Immunity, Infection and Evolution, University of Edinburgh, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>Donald B</ForeName>
<Initials>DB</Initials>
<AffiliationInfo>
<Affiliation>Centre for Immunity, Infection and Evolution, University of Edinburgh, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vine</LastName>
<ForeName>Louisa</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>The Royal Cornwall Hospital, Truro, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McLaughlin</LastName>
<ForeName>Cara</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>The Royal Cornwall Hospital, Truro, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Collier</LastName>
<ForeName>Jane</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bonsall</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jeffery</LastName>
<ForeName>Katie</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dunachie</LastName>
<ForeName>Susanna</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Klenerman</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>National Institute for Health Research (NIHR), Oxford Biomedical Research Centre, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Izopet</LastName>
<ForeName>Jacques</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>The Rangueil Hospital, Toulouse, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kamar</LastName>
<ForeName>Nassim</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>The Rangueil Hospital, Toulouse, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dalton</LastName>
<ForeName>Harry R</ForeName>
<Initials>HR</Initials>
<AffiliationInfo>
<Affiliation>The Royal Cornwall Hospital, Truro, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barnes</LastName>
<ForeName>Eleanor</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>National Institute for Health Research (NIHR), Oxford Biomedical Research Centre, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>091663</GrantID>
<Agency>Wellcome Trust</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>MR/K010239/1</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>10</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Hepatology</MedlineTA>
<NlmUniqueID>8302946</NlmUniqueID>
<ISSNLinking>0270-9139</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>82115-62-6</RegistryNumber>
<NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Intern Med. 2009 Mar 17;150(6):430-1</RefSource>
<PMID Version="1">19293084</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Med Virol. 2010 May;82(5):799-805</RefSource>
<PMID Version="1">20336757</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Liver Transpl. 2008 Apr;14(4):547-53</RefSource>
<PMID Version="1">18383084</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Viral Hepat. 2011 Mar;18(3):227-8</RefSource>
<PMID Version="1">20384963</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2007 Mar 1;356(9):895-903</RefSource>
<PMID Version="1">17329696</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vaccine. 2005 Apr 22;23(22):2893-901</RefSource>
<PMID Version="1">15780738</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Virol. 2012 Nov;93(Pt 11):2408-18</RefSource>
<PMID Version="1">22837418</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Viral Hepat. 2010 Aug;17(8):598-9</RefSource>
<PMID Version="1">20002566</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Viral Hepat. 2007 Apr;14(4):283-92</RefSource>
<PMID Version="1">17381721</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vox Sang. 2015 Nov;109(4):406-9</RefSource>
<PMID Version="1">26031310</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol Methods. 1992 Jul;38(1):175-86</RefSource>
<PMID Version="1">1644893</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Indian Pediatr. 2006 Apr;43(4):365-6</RefSource>
<PMID Version="1">16651680</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Immunol. 2014 Jan;14(1):24-35</RefSource>
<PMID Version="1">24336101</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEMS Microbiol Lett. 1993 May 15;109(2-3):251-5</RefSource>
<PMID Version="1">7687968</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Virol. 2000;145(7):1321-37</RefSource>
<PMID Version="1">10963340</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Virus Res. 2011 Oct;161(1):3-14</RefSource>
<PMID Version="1">21320558</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Gastroenterol. 2000 Dec;95(12):3667-8</RefSource>
<PMID Version="1">11151929</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2012 Mar;55(3):695-708</RefSource>
<PMID Version="1">22006345</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Evol. 2013 Dec;30(12):2725-9</RefSource>
<PMID Version="1">24132122</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10160-5</RefSource>
<PMID Version="1">20439706</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hepatol. 2009 Mar;50(3):622-4</RefSource>
<PMID Version="1">19157619</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Virology. 1991 Nov;185(1):120-31</RefSource>
<PMID Version="1">1926770</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Res Notes. 2012 Jan 20;5:50</RefSource>
<PMID Version="1">22264264</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2000 Sep;74(17):8011-7</RefSource>
<PMID Version="1">10933710</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Virol. 2016 Jan;74:82-7</RefSource>
<PMID Version="1">26687439</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2012 Apr;55(4):988-97</RefSource>
<PMID Version="1">22121109</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Virol. 2015 Apr;11:130-6</RefSource>
<PMID Version="1">25913817</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Emerg Infect Dis. 2006 Nov;12(11):1682-8</RefSource>
<PMID Version="1">17283617</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>F1000Res. 2015 Oct 13;4:1062</RefSource>
<PMID Version="1">27092241</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gastroenterol Hepatol. 2005 Jul;20(7):1094-101</RefSource>
<PMID Version="1">15955220</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Virology. 1993 May;194(1):89-96</RefSource>
<PMID Version="1">7683162</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Diagn Lab Immunol. 2002 Sep;9(5):1072-8</RefSource>
<PMID Version="1">12204962</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Viral Hepat. 1999 Nov;6(6):457-61</RefSource>
<PMID Version="1">10607264</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Liver Transpl. 2010 Jan;16(1):74-82</RefSource>
<PMID Version="1">19866448</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Emerg Infect Dis. 2009 Jan;15(1):110-4</RefSource>
<PMID Version="1">19116067</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Infect Dis. 2008 Nov;8(11):698-709</RefSource>
<PMID Version="1">18992406</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gut. 2016 Jan;65(1):112-23</RefSource>
<PMID Version="1">26092843</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Virol. 2015 Nov;96(11):3255-64</RefSource>
<PMID Version="1">26282123</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2014 Jan 21;9(1):e85330</RefSource>
<PMID Version="1">24465537</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Viral Immunol. 2007 Spring;20(1):56-65</RefSource>
<PMID Version="1">17425421</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Virol. 2016 Mar;97(3):537-42</RefSource>
<PMID Version="1">26743685</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hepatol. 2011 Jun;54(6):1323-4; author reply 1324-5</RefSource>
<PMID Version="1">21281681</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Emerg Infect Dis. 2011 Dec;17(12):2309-12</RefSource>
<PMID Version="1">22172156</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Immunol. 2003 Dec;4(12):1191-8</RefSource>
<PMID Version="1">14625547</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gastroenterol Hepatol. 2008 Jun;23(6):883-7</RefSource>
<PMID Version="1">18070014</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2006 Apr;80(7):3532-40</RefSource>
<PMID Version="1">16537621</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Microbes Infect. 2002 May;4(6):657-66</RefSource>
<PMID Version="1">12048035</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Viral Hepat. 2003 Jan;10(1):61-9</RefSource>
<PMID Version="1">12558914</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Microbiol. 2011 Apr;49(4):1234-9</RefSource>
<PMID Version="1">21307208</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Med Virol. 1992 Apr;36(4):246-50</RefSource>
<PMID Version="1">1578218</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>World J Gastroenterol. 2013 Sep 21;19(35):5904-9</RefSource>
<PMID Version="1">24124337</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Viral Hepat. 2016 Feb;23 (2):68-79</RefSource>
<PMID Version="1">26344932</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2008 Feb 21;358(8):811-7</RefSource>
<PMID Version="1">18287603</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gastroenterol Hepatol. 2011 Feb;26(2):306-11</RefSource>
<PMID Version="1">21143520</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2014 Feb 11;82(6):491-7</RefSource>
<PMID Version="1">24415572</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(2):e31822</RefSource>
<PMID Version="1">22384080</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2015 Mar 5;372(10):914-22</RefSource>
<PMID Version="1">25738667</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2001 Nov 9;276(45):42389-400</RefSource>
<PMID Version="1">11518702</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Neurol Neurosurg. 2009 Feb;111(2):193-5</RefSource>
<PMID Version="1">18986757</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2010 Sep 11;376(9744):895-902</RefSource>
<PMID Version="1">20728932</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Microbiol. 1999 Sep;37(9):2863-71</RefSource>
<PMID Version="1">10449466</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Med. 1981 Feb;70(2):252-5</RefSource>
<PMID Version="1">6781338</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2005 May 15;174(10):5926-30</RefSource>
<PMID Version="1">15879083</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016751" MajorTopicYN="N">Hepatitis E</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016752" MajorTopicYN="N">Hepatitis E virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D037182" MajorTopicYN="Y">T-Cell Antigen Receptor Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>02</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2016</Year>
<Month>07</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2016</Year>
<Month>08</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>10</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>8</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>9</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27631819</ArticleId>
<ArticleId IdType="doi">10.1002/hep.28819</ArticleId>
<ArticleId IdType="pmc">PMC5132006</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Midi-Pyrénées</li>
<li>Occitanie (région administrative)</li>
<li>Oxfordshire</li>
<li>Écosse</li>
</region>
<settlement>
<li>Oxford</li>
<li>Toulouse</li>
<li>Édimbourg</li>
</settlement>
<orgName>
<li>Université d'Oxford</li>
<li>Université d'Édimbourg</li>
</orgName>
</list>
<tree>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Brown, Anthony" sort="Brown, Anthony" uniqKey="Brown A" first="Anthony" last="Brown">Anthony Brown</name>
</region>
<name sortKey="Barnes, Eleanor" sort="Barnes, Eleanor" uniqKey="Barnes E" first="Eleanor" last="Barnes">Eleanor Barnes</name>
<name sortKey="Bendall, Richard" sort="Bendall, Richard" uniqKey="Bendall R" first="Richard" last="Bendall">Richard Bendall</name>
<name sortKey="Bonsall, David" sort="Bonsall, David" uniqKey="Bonsall D" first="David" last="Bonsall">David Bonsall</name>
<name sortKey="Collier, Jane" sort="Collier, Jane" uniqKey="Collier J" first="Jane" last="Collier">Jane Collier</name>
<name sortKey="Dalton, Harry R" sort="Dalton, Harry R" uniqKey="Dalton H" first="Harry R" last="Dalton">Harry R. Dalton</name>
<name sortKey="Dunachie, Susanna" sort="Dunachie, Susanna" uniqKey="Dunachie S" first="Susanna" last="Dunachie">Susanna Dunachie</name>
<name sortKey="Halliday, John S" sort="Halliday, John S" uniqKey="Halliday J" first="John S" last="Halliday">John S. Halliday</name>
<name sortKey="Hunter, Jeremy G" sort="Hunter, Jeremy G" uniqKey="Hunter J" first="Jeremy G" last="Hunter">Jeremy G. Hunter</name>
<name sortKey="Jeffery, Katie" sort="Jeffery, Katie" uniqKey="Jeffery K" first="Katie" last="Jeffery">Katie Jeffery</name>
<name sortKey="Klenerman, Paul" sort="Klenerman, Paul" uniqKey="Klenerman P" first="Paul" last="Klenerman">Paul Klenerman</name>
<name sortKey="Madden, Richie G" sort="Madden, Richie G" uniqKey="Madden R" first="Richie G" last="Madden">Richie G. Madden</name>
<name sortKey="Maggs, James" sort="Maggs, James" uniqKey="Maggs J" first="James" last="Maggs">James Maggs</name>
<name sortKey="Mclaughlin, Cara" sort="Mclaughlin, Cara" uniqKey="Mclaughlin C" first="Cara" last="Mclaughlin">Cara Mclaughlin</name>
<name sortKey="Simmonds, Peter" sort="Simmonds, Peter" uniqKey="Simmonds P" first="Peter" last="Simmonds">Peter Simmonds</name>
<name sortKey="Smith, Donald B" sort="Smith, Donald B" uniqKey="Smith D" first="Donald B" last="Smith">Donald B. Smith</name>
<name sortKey="Swadling, Leo" sort="Swadling, Leo" uniqKey="Swadling L" first="Leo" last="Swadling">Leo Swadling</name>
<name sortKey="Vine, Louisa" sort="Vine, Louisa" uniqKey="Vine L" first="Louisa" last="Vine">Louisa Vine</name>
</country>
<country name="France">
<region name="Occitanie (région administrative)">
<name sortKey="Izopet, Jacques" sort="Izopet, Jacques" uniqKey="Izopet J" first="Jacques" last="Izopet">Jacques Izopet</name>
</region>
<name sortKey="Kamar, Nassim" sort="Kamar, Nassim" uniqKey="Kamar N" first="Nassim" last="Kamar">Nassim Kamar</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B45 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 003B45 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:27631819
   |texte=   Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:27631819" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024